Search results
Results From The WOW.Com Content Network
Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International, Inc.) is an American-Canadian multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health ...
J. Michael Pearson (born 1959) is a Canadian American [1] pharmaceutical company executive. He is the former chairman and CEO of Valeant Pharmaceuticals International [2][3] after being ousted in the aftermath of a report on pharmaceutical pricing published by Citron Research in April 2016. [4]
From 1985 onward, ADP's annual revenues exceeded the $1 billion mark, with paychecks processed for about 20% of the U.S. workforce. In the 1990s, ADP began acting as a professional employer organization (PEO). Around this time, the company acquired Autonom, a German company, [6][7] and the payroll and human resource services company, GSI, headquartered in Paris. [8] In September 1998, ADP ...
Philidor Rx Services is a Pennsylvania-licensed specialty online pharmacy, which mainly sold [4][5] Valeant Pharmaceuticals International Inc drugs directly to patients and handled insurance claims on the customers' behalf. [1][6]
For premium support please call: 800-290-4726 more ways to reach us
Prior to joining Valeant, Papa was the chairman and CEO of Perrigo, an American manufacturer of private label over-the-counter pharmaceuticals, from 2006 to 2016. [8] From December 2004 to October 2006, Papa was chairman and CEO of the pharmaceutical and technologies services of Cardinal Health, an Ohio health care services company.
Contrarian investor Jim Grant recently wrote that he's "confidently bearish" on Valeant Pharmaceuticals in a Grant's Interest Rate Observer article, making his case against the skin- and eye-care ...
AOL Mail offers a free email service with customizable themes, tabs, and document views to enhance your inbox experience.